MétaCan
Menu
Back to cohort
Record W4416145127 · doi:10.1002/bcp.70324

Reference range of rivaroxaban‐calibrated anti‐Xa activity in Chinese children with giant coronary artery aneurysms after KawasakI disease: insights from a population pharmacokinetic and pharmacodynamic analysis

2025· article· en· W4416145127 on OpenAlexaff
Bijue Liu, Guangan Dai, Nuo Xu, Xin Liu, Wen Yao Mak, L. Zhang, Leonardo R. Brandão, Guoying Huang, Fang Liu, Xiao Zhu

Bibliographic record

VenueBritish Journal of Clinical Pharmacology · 2025
Typearticle
Languageen
FieldMedicine
TopicKawasaki Disease and Coronary Complications
Canadian institutionsHospital for Sick Children
FundersNational Natural Science Foundation of China
KeywordsPharmacokineticsPharmacodynamicsAntithromboticRivaroxabanPopulationReference rangeChinese population

Abstract

fetched live from OpenAlex

Aims This study aimed to characterize the pharmacokinetics of rivaroxaban and its correlation with anti‐Xa activity and recommend reference range of anti‐Xa activity in Chinese children with giant coronary artery aneurysm (GCAA) after Kawasaki disease (KD). Methods Sparse sampling rivaroxaban concentration (C riva ) and anti‐Xa activity data from a prospective observational study conducted in the preceding population were analysed using NONMEM. The pharmacokinetic‐pharmacodynamic (PK/PD) model was developed sequentially following a PPP&D modelling approach. The patients' kinetic profiles of anti‐Xa activity were estimated by a Bayesian approach based on individual PK/PD parameters. Echocardiograms, coronary artery angiograms and clinical symptom evaluations were used to assess the effectiveness and safety of the clinically used dose regimen. Results This study included 35 children, with 145 rivaroxaban concentrations and 85 anti‐Xa measurements collected. A two‐compartment model with first‐order elimination best described the PK data. A linear model (Anti‐Xa = 0.945 × C riva + 4.37) was chosen to describe the relationship between C riva (within 0.5–500 ng/mL) and anti‐Xa activity. Anti‐Xa activity of patients, who all responded well to the medication, was regarded as the reference range for balancing the therapeutic effect and safety in Chinese paediatrics with GCAA after KD. The recommended anti‐Xa activity range is 50.9–187.3 ng/mL at peak (2–4 h after last dose), and 5.8–24.1 ng/mL at trough (22–24 h after last dose). Conclusions The developed population PK/PD model could be used to describe C riva and anti‐Xa activity simultaneously. The recommended anti‐Xa range could inform rivaroxaban use in Chinese children with GCAA after KD under dual antithrombotic therapy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.011
Threshold uncertainty score0.021

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.353
Teacher spread0.338 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueBritish Journal of Clinical PharmacologySame topicKawasaki Disease and Coronary ComplicationsFrench-language works237,207